Physician profile
Ciro Amodio
NPI 1063275360
$2,433.06
in general payments reported to CMS, 2019-2025
9 companies · $1,218 in 2025
The $1,218 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,215 · 2025: $1,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,265 · Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,265.28 |
| Food and Beverage | $1,167.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $1,406.05 | 2024-2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| Atricure, INC. | $344.28 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Artivion, INC. | $178.09 | 2025 | Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Edwards Lifesciences Corporation | $167.54 | 2025 | |
| Depuy Synthes Sales INC. | $133.68 | 2025 | Matrixrib, Na, Zipfix |
| Arthrex, INC. | $83.96 | 2025 | |
| Ethicon US, LLC | $64.25 | 2025 | Dermabond Prineo |
| Medical Device Business Services, INC. | $30.64 | 2025 | Vistaseal |
| Smith+Nephew, INC. | $24.57 | 2025 | Pico 14 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ciro Amodio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.